The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 18053726 |
364 |
Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. |
Johnson & Johnson Pharmaceutical Research & Development |
| 19743866 |
16 |
Structure-activity relationships for substrate-based inhibitors of human complement factor B. |
The University of Queensland |
| 17921140 |
1 |
Profiling the enzymatic properties and inhibition of human complement factor B. |
University of Queensland |
| 32073845 |
74 |
Discovery of 4-((2 S,4 S)-4-Ethoxy-1-((5-methoxy-7-methyl-1 H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases |
Novartis Institutes For Biomedical Research |
| 28977749 |
75 |
Chemical Approaches to Modulating Complement-Mediated Diseases. |
The University of Queensland |
| 16249081 |
7 |
Macrocyclic peptidomimetic inhibitors of beta-secretase (BACE): first X-ray structure of a macrocyclic peptidomimetic-BACE complex. |
Eli Lilly |
| 9240358 |
40 |
Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 6. 2-Indol-3-yl- and 2-azaindol-3-yl-dipyridodiazepinones. |
Boehringer Ingelheim Pharmaceuticals |
| 10737742 |
23 |
2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors. |
Boehringer Ingelheim Pharmaceuticals |
Search and Browse
